JLJing-Yi Li

Jing-Yi Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jing-Yi Li has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Cheng Zhang

    Department of Biliary Minimally Invasive Surgery, Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, Liaoning Province, China

    1 shared publication
  • Chun-Chun Qi

    Department of Biliary Minimally Invasive Surgery, Affiliated Zhongshan Hospital of Dalian University, No, 6. Jiefang Road, Zhongshan District, Dalian, Liaoning Province, 116001, People’s Republic of China

    1 shared publication
  • Hongwei Zhang

    Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, China

    1 shared publication
  • Li-Jun Shi

    Department of Ophthalmology, The Second Hospital of Jilin University, 4026 Yatai Street, Changchun City 130000, China

    1 shared publication
  • Mei-Ju Lin

    Department of Biliary Minimally Invasive Surgery, Affiliated Zhongshan Hospital of Dalian University, No, 6. Jiefang Road, Zhongshan District, Dalian, Liaoning Province, 116001, People’s Republic of China

    1 shared publication
  • Yu-Long Yang

    Center of Gallbladder Disease

    1 shared publication

Latest Publications

  • Open Access

    The modified pancreatic stent system for prevention of post-ERCP pancreatitis: a case-control study

    by Cheng Zhang, Yu-Long Yang, Yue-Feng Ma, Hong-Wei Zhang, Jing-Yi Li, Mei-Ju Lin, Li-Jun Shi, Chun-Chun Qi

    Prophylactic pancreatic stents after endoscopic retrograde cholangiopancreatography (ERCP) can help prevent post-ERCP pancreatitis. However most of the pancreatic stents need to be removed by another ERCP. The aim of this observational study was to investigate the feasibility and effectiveness of the modified pancreatic stent system for prevention of post-ERCP pancreatitis. From November 2013 to November 2015, a total of 230 patients who had prophylactic pancreatic stent placed for prevention of post-ERCP pancreatitis at a single institution were identified and stratified. In this case-control design, 150 patients received an ordinary pancreatic stent, and 80 patients received the modified pancreatic stent. The main outcome measures were the difficulty level and complications of pancreatic stent placement and extraction between the two groups. In ordinary group, the average time of pancreatic stent and nasal biliary drainage placement was 3.5 ± 0.6 min. There were 13 cases of stent proximal migration (8.7%), 20 cases of stent spontaneous abscission (13.3%), 5 cases of acute pancreatitis (3.3%) (2 cases for stent abscission) and 7 cases of hyperamylasemia (4.7%) after ERCP. One hundred thirty patients received extra duodenoscope (86.7%) to remove the stent, and 4 cases had acute pancreatitis and 5 patients had hyperamylasemia after removing the proximal migratory stents. In modified group, the average time of pancreatic stent system placement was 4.9 ± 0.7 min, but there was only one case of stent abscission (1.3%), 2 cases of acute pancreatitis (2.5%) and 3 cases of hyperamylasemia (3.8%). The new pancreatic stents were removed directly under x-ray without complication. The modified pancreatic stent system has the same effect of preventing post-ERCP pancreatitis, lower rate of stents proximal migration and spontaneous abscission, and the advantage of easier removed compared with ordinary pancreatic stent.